Epilepsy GTx
HealthcareBiotech & Pharma
HQ: Canterbury, United Kingdom
Investors: 1
Providing seizure freedom for patients with focal refractory epilepsy
Investors (1)
| Fund | Status | Entry Date | Stage | Source |
|---|---|---|---|---|
| XGen Venture SGR | Current | - | - | Website |
Get these signals delivered weekly
Deals, exits, fundraises, and key hires from funds active in Italy — straight to your inbox.
Get SignalsSignals (1)
PortfolioXGen Venture SGR
2026-02-08 (observed)New portfolio investment: Epilepsy GTx in Life Sciences sector
Source: XGen Venture SGR